Salubre Pharmaceuticals invested $3.4 billion dollars to develop a new drug for individuals with diabetes. After Salubre receives FDA approval of the drug, its marginal cost to produce the drug for market will be

Question

Quizplus · Accepted Answer

Although the initial investments to create the first version of a new product or service is quite high in many knowledge-intensive industries, the marginal cost (the cost to produce the next unit) after initial invention is generally quite low.

Salubre Pharmaceuticals Invested $3